ABO incompatible renal transplantation in an HIV-seropositive patient

Transplantation

Volumn 86, Issue 1, 2008, Pages 176-178

  Campara, Maya ^a   West Thielke, Patricia ^a   Thielke, James ^a   Ommert, Thuy ^a   Oberholzer, Jose ^a   Benedetti, Enrico ^a   Kaplan, Bruce ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

ABO incompatibility; HIV; Renal transplant

Indexed keywords

ABACAVIR PLUS LAMIVUDINE; CORTICOSTEROID; COTRIMOXAZOLE; CREATININE; DACLIZUMAB; EFAVIRENZ; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; STEROID; TACROLIMUS; VALGANCICLOVIR; ZIDOVUDINE; IMMUNOSUPPRESSIVE AGENT;

ACUTE GRAFT REJECTION; ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD GROUP ABO INCOMPATIBILITY; CASE REPORT; CD4 LYMPHOCYTE COUNT; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG MEGADOSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; ORGAN DONOR; PLASMAPHERESIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SPLENECTOMY; SPOUSE; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLOOD; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; CHRONIC KIDNEY FAILURE; DESENSITIZATION; GRAFT REJECTION; HISTOCOMPATIBILITY TEST; IMMUNOLOGY; LIVING DONOR; METHODOLOGY; MIDDLE AGED; TREATMENT OUTCOME; VIROLOGY;

ABO BLOOD-GROUP SYSTEM; ADRENAL CORTEX HORMONES; AIDS-ASSOCIATED NEPHROPATHY; BLOOD GROUP INCOMPATIBILITY; DESENSITIZATION, IMMUNOLOGIC; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HIV SEROPOSITIVITY; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PLASMAPHERESIS; TREATMENT OUTCOME;

EID: 49849099938     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31817cf403     Document Type: Article

References (19)

1. USRDS 2004 Annual Data Report. Am J Kidney Dis 2005;45: 8.
2. Tzakis AG, Cooper MH, Dummer JS, et al. Transplantation in HIV+ patients. Transplantation 1990; 49: 354.
3. Erice A, Rhame FS, Heussner RC, et al. Human immunodeficiency virus infection in patients with solid-organ transplants: Report of five cases and review. Rev Infect Dis 1991; 13: 537.
4. Roland ME, Stock PG. Review of solid-organ Transplantation in HIV-infected patients. Transplantation 2003; 75: 425.
5. Stock PG, Roland ME, Carlson L, et al. Kidney and liver Transplantation in human immunodeficiency virus-infected patients: A pilot safety and efficacy study. Transplantation 2003; 76: 370.
6. Abbott KC, Swanson SJ, Agodoa LY, et al. Human immunodeficiency virus infection and kidney Transplantation in the era of highly active antiretroviral therapy and modern immunosuppression. J Am Soc Nephrol 2004; 15: 1633.
7. Pelletier SJ, Norman SP, Christensen LL, et al. Review of transplantation in HIV patients during the HAART era. Clin Transpl 2004; 63.
8. Kumar MS, Sierka DR, Damask AM, et al. Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients. Kidney Int 2005; 67: 1622.
9. Steinman TI, Becker BN, Frost AE, et al. Guidelines for the referral and management of patients eligible for solid organ transplantation. Transplantation 2001; 71: 1189.
10. Futagawa Y, Terasaki PI. ABO incompatible kidney transplantation - An analysis of UNOS Registry data. Clin Transpl 2006; 20: 122.
11. Sawada T, Fuchinoue S, Kawase T, et al. Preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy and DFPP-enabled non-responders to undergo ABO-incompatible kidney transplantation. Clin Transplant 2004; 18: 254.
12. Tyden G, Donauer J, Wadström J, et al. Implementation of a Protocol for ABO-incompatible kidney transplantation - A three-center experience with 60 consecutive transplantations. Transplantation 2007; 83: 1153.
13. Gloor JM, Stegall MD. ABO incompatible kidney transplantation. Curr Opin Nephrol Hypertens 2007; 16: 529.
14. Shimmura H, Tanabe K, Ishikawa N, et al. Removal of anti-A/B antibodies with plasmapheresis in ABO-incompatible kidney transplantation. Ther Apher 2000; 4: 395.
15. Rubin RH, Jenkins RL, Shaw BW Jr, et al. The acquired immunodeficiency syndrome and transplantation. Transplantation 1987; 44: 1.
16. Kumar MSA, Panigrahi D, Dezii CM, et al. Long-term survival of elderly donor kidneys transplanted into young adults. Transplantation 1998; 65: 282.
17. Swanson SJ, Kirk AD, Ko CW, et al. Impact of HIV seropositivity on graft and patient survival after cadaveric renal transplantation in the United States in the pre highly active antiretroviral therapy (HAART) era: An historical cohort analysis of the United States Renal Data System. Transpl Infect Dis 2002; 4: 144.
18. Carter JT, Melcher ML, Carlson LL, et al. Thymoglobulin-associated Cd4+ T-cell depletion and infection risk in HIV-infected renal transplant recipients. Am J Transplant 2006; 6: 753.
19. Roland ME, Barin B, Carlson L, et al. HIV-infected liver and kidney transplant recipients: 1- and 3-year outcomes. Am J Transplant 2007; 7: 1.